Position in AZN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$86,329,814
-$7,536,650 QoQ
Shares Held
455,278
-4.3% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#132
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $4,788,622,872 across 16 Drug Manufacturers - General names. AZN ranks #7 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
9,892,767 | $2,512,466,034 | |
| 2 | LLY |
ELI LILLY & Co
|
436,561 | $523,624,403 | |
| 3 | ABBV |
AbbVie Inc.
|
1,967,343 | $495,062,192 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,679,920 | $472,869,720 | |
| 5 | AMGN |
Amgen Inc
|
816,257 | $295,582,984 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,534,627 | $193,884,775 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
455,278 | $86,329,814 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,126,721 | $64,921,664 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $86,329,814 | 455,278 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $93,866,464 | 475,948 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||